Fukuoka K | National Cancer Center Res. Inst.
スポンサーリンク
概要
関連著者
-
Kanzawa Fumihiko
国立がんセンター
-
Kanzawa Fumihiko
Pharmacology:pathology Division National Cancer Center Research Institute:surgery Division:departmen
-
Fukuoka K
National Cancer Center Res. Inst.
-
Saijo N
Division Of Internal Medicine National Cancer Center Hospital East
-
Saijo Nagahiro
国立医薬品食品衛生研究所
-
Saijo N
Medical Oncology National Cancer Center Hospital
-
Saijo Nagahiro
Pharmacology Division, National Cancer Center Research Institute
-
Saijo Nagahiro
Pharmacology Division National Cancer Center Research Institute
-
Nishio K
Department Of Genome Biology Kinki University School Of Medicine
-
Kuzuya Nobuaki
国立医薬食品衛生研究所 薬物応答予測プロジェクト
-
NISHIO Kazuto
Pharmacology Division, National Cancer Center Research Institute
-
Nishio Kazuto
Pharmacology Division National Cancer Center Research Institute
-
ARIOKA Hitoshi
Pharmacology Division, National Cancer Center Research Institute
-
ISHIDA Tomoyuki
Pharmacology Division, National Cancer Center Research Institute
-
FUKUOKA Kazuya
Pharmacology Division, National Cancer Center Research Institute
-
Ishida Tomoyuki
Pharmacology Division National Cancer Center Research Institute
-
Ishida Tomoyuki
国立がんセンター
-
Arioka H
National Cancer Center Res. Inst.
-
Arioka Hiroshi
国立がんセンター
-
Arioka Hitoshi
国立がんセンター中央病院
-
Arioka Hitoshi
Pharmacology Division National Cancer Center Research Institute
-
Fukuoka Kazuya
Pharmacology Division National Cancer Center Research Institute
-
FUKUMOTO Hisao
Pharmacology Division, National Cancer Center Research Institute
-
KUROKAWA Hirokazu
Pharmacology Division, National Cancer Center Research Institute
-
Fukumoto H
National Cancer Center Res. Inst.
-
Fukumoto Hisao
国立がんセンター
-
Fukumoto Hisao
Pharmacology Division Natonal Cancer Center Research Instiute
-
Fukumoto Hisao
Pharmacology Division National Cancer Center Research Institute
-
Kurokawa Hirokazu
Pharmacology Division National Cancer Center Research Institute
-
Kurokawa Hirokazu
国立がんセンター
-
Matsushima Y
Pharmacology:pathology Division National Cancer Center Research Institute:surgery Division:departmen
-
Kaniwa N
Department Of Genome Biology Kinki University School Of Medicine
-
NISHIO Kazuto
Department of Genome Biology, Kinki University School of Medicine
-
NOMOTO Taisuke
Pharmacology Division, National Cancer Center Research Institute
-
Kanzawa Fumihiko
Pharmacology Division National Cancer Center Research Institute
-
Nomoto T
Pharmacology Division National Cancer Center Research Institute
-
Nomoto Taisuke
国立がんセンター
-
Nomoto Taisuke
Pharmacology Division National Cancer Center Research Institute
-
Saijo Nagahiro
Department Of Internal Medicine National Cancer Center Hospital
-
YOKOTE Hideyuki
Shien-Laboratory, National Cancer Center Hospital
-
YOKOTE Hideyuki
Pharmacology Division, National Cancer Center Research Institute
-
Yokote Hideyuki
近畿大学 医学部ゲノム生物学
-
Yokote H
Shien-laboratory National Cancer Center Hospital
-
Yokote Hideyuki
Department Of Genome Biology Kinki University School Of Medicine
-
Yokote Hideyuki
Pharmacology Division National Cancer Center Research Institute
-
MATSUSHIMA YUKA
Pharmacology
-
Sasaki Y
Mitsubishi Kasei Corporation Research Center:school Of Pharmaceutical Sciences Kitasato University
-
Ishihara J
Epidemiology And Prevention Division Research Center For Cancer Prevention And Screening National Ca
-
Ogasawara H
Pharmacology Division National Cancer Center Research Institute
-
Ogasawara Hayato
国立がんセンター
-
Ogasawara Hayato
Pharmacology Division National Cancer Center Research Institute
-
CHIANG CHIDER
Pharmacology
-
NAKANO HIDEHIKO
Pharmacology
-
NAKAGAWA KAZUHIKO
Pharmacology
-
TAKAHASHI HIDENOBU
Pharmacology
-
SASAKI YASUTSUNA
Pharmacology
-
Nakagawa Kazuhiko
Pharmacology:pathology Division National Cancer Center Research Institute:surgery Division:departmen
-
ISHIHARA JUNICHI
Pharmacology Division, National Cancer Center Research Institute
-
Takahashi H
Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
-
Shimizu E
Osaka City Univ. Osaka‐shi Jpn
-
Chiang Chider
Pharmacology:pathology Division National Cancer Center Research Institute:surgery Division:departmen
-
Miyazawa Naoto
Surgery Division National Cancer Center Hospital
-
Nakano H
Department Of Applied Chemistry Himeji Institute Of Technology
-
OKA MIKIO
Second Department of Internal Medicine, Nagasaki University School of Medicine
-
Ohe Yuichiro
Medical Oncology National Cancer Center Hospital
-
Ohe Yuichiro
Department Of Medical Oncology National Cancer Center Hospital
-
Ohe Yuichiro
Department Of Internal Medicine National Cancer Center Hospital
-
YOKOTA Jun
Biology Division, National Cancer Center Research Institute
-
Yoshida Shigeaki
国立がんセンター東病院 消化管内科
-
ABE Shosaku
Third Division, Department of Internal Medicine, Sapporo Medical University School of Medicine
-
OGASAWARA Hayato
Pharmacology Division, National Cancer Center Research Institute
-
ADACHI Jun-ichi
Biology Division, National Cancer Center Research Institute
-
TOMONARI Akira
Pharmacology Division, National Cancer Center Research Institute
-
NARITA Nobuhiro
Second Department of Internal Medicine, Nara Medical University
-
NISHIO Makoto
Division of Internal Medicine, Cancer Institute Hospital
-
HEIKE Yuji
Pharmacology Division, National Cancer Center Research Institute
-
FUKUDA Minoru
Department of Medical Oncology, National Cancer Center Hospital
-
INOMATA Motoko
Pharmacology Division, National Cancer Center Research Institute
-
KANZAWA Fumihiko
Pharmacology Division, National Cancer Center Research Institute
-
Tomonari Akira
Pharmacology Division National Cancer Center Research Institute
-
Hoshi Akio
Pharmacology Division National Cancer Center Research Institute
-
Abe Shosaku
Third Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Fukuoka Kazuya
国立がんセンター
-
Heike Yuji
国立がんセンター中央病院
-
Heike Y
Pharmacology Division National Cancer Center Research Institute
-
Inomata Motoko
Pharmacology Division National Cancer Center Research Institute
-
Inomata Motoko
国立がんセンター中央病院
-
Eguchi Kenji
Department Of Medical Oncology National Cancer Center Hospital
-
Shinkai Tetsu
Department Of Medical Oncology National Cancer Center Hospital
-
Terada Masaaki
Pharmacology:pathology Division National Cancer Center Research Institute:surgery Division:departmen
-
LEE Yong-Sik
Pharmacology Division, National Cancer Center Research Institute
-
FUNAYAMA Yasunori
Pharmacology Division, National Cancer Center Research Institute
-
OHIRA Tatsuo
Pharmacology Division, National Cancer Center Research Institute
-
KURAISHI Yasunobu
The Third Department of Internal Medicine, Jikei University School of Medicine
-
ISOGAI Yukihide
The Third Department of Internal Medicine, Jikei University School of Medicine
-
Hoshi Akio
Pharmaceutical Development Laboratories Meiji Seika Kaisha Ltd. : Central Research Laboratories Meij
-
WATANABE KENZO
Bio-Medical Research Institute, Teijin Limited
-
Tsuchiya R
Pharmacology:pathology Division National Cancer Center Research Institute:surgery Division:departmen
-
KANAZAWA FUMIHIKO
Pharmacology
-
MORINAGA SHOJIRO
Pharmacology
-
TSUCHIYA RYOSUKE
Pharmacology
-
Isogai Yukihide
The Third Department Of Internal Medicine Jikei University School Of Medicine
-
Fukuda Minoru
Department Of Medical Oncology National Cancer Center Hospital
-
MIYAZAWA NAOTO
Department of Surgery Division National Cancer Center Hospital
-
Oka Mikio
Second Department Of Internal Medicine Nagasaki University School Of Medicine
-
Heike Yuji
Pharmacology Division National Cancer Center Research Institute
-
Abe S
Keio Univ. Tokyo
-
Ohira Tatsuo
Pharmacology Division National Cancer Canter Research Institute
-
Fukuda Minoru
Department Of Anatomy Kyorin University School Of Medicine
-
SHIMIZU EIJI
Internal Medicine National Cancer Center Hospital
-
SASAKI YASUTSUNA
Internal Medicine National Cancer Center Hospital
-
EGUCHI KENJI
Internal Medicine National Cancer Center Hospital
-
SHINKAI TETSU
Internal Medicine National Cancer Center Hospital
-
SAIJO NAGAHIRO
Internal Medicine National Cancer Center Hospital
-
HAMBURGER ANNE
University of Maryland Cancer Center
-
Fukuoka K
Pharmacology Division National Cancer Center Research Institute
-
Adachi J
Biology Division National Cancer Center Research Institute
-
Nishio Makoto
Division Of Internal Medicine Cancer Institute Hospital
-
Funayama Yasunori
Pharmacology Division National Cancer Center Research Institute
-
Lee Yong-sik
Pharmacology Division National Cancer Center Research Institute
-
Watanabe K
Bio-medical Research Institute Teijin Limited
-
Yokota J
National Cancer Center Res. Inst. Tokyo
-
Yokota Jun
Biology Division National Cancer Center Research Institute
-
Ohira Tatsuo
Pharmacology Division National Cancer Center Research Institute
-
Morinaga Shojiro
Pharmacology:pathology Division National Cancer Center Research Institute:surgery Division:departmen
-
Kuraishi Yasunobu
The Third Department Of Internal Medicine Jikei University School Of Medicine
-
Narita N
Shibaura Inst. Of Technol. Tokyo
-
Narita Nobuhiro
Second Department Of Internal Medicine Nara Medical University
著作論文
- Enhancement of Cisplatin Sensitivity in High Mobility Group 2 cDNA-transfected Human Lung Cancer Cells
- In vitro Enhancement of Antitumor Activity of a Water-soluble Duocarmycin Derivative, KW-2189, by Caffeine-mediated DNA-repair Inhibition in Human Lung Cancer Cells
- p16^ Expression Is Associated with the Increased Sensitivity of Human Non-small Cell Lung Cancer Cells to DNA Topoisomerase I Inhibitors
- Interferon-γ-inducing Factor Gene Transfection into Lewis Lung Carcinoma Cells Reduces Tumorigenicity in vivo
- Effect of Glutathione Depletion on Cisplatin Resistance in Cancer Cells Transfected with the γ-Glutamylcysteine Synthetase Gene
- A Topoisomerase II Inhibitor, NK109, Induces DNA Single- and Double-strand Breaks and Apoptosis
- Intracellular Carboxyl Esterase Activity Is a Determinant of Cellular Sensitivity to the Antineoplastic Agent KW-2189 in Cell Lines Resistant to Cisplatin and CPT-11
- ANTITUMOR ACTIVITY OF ALKYLESTERS OF 5-FLUORO-2'-DEOXYURIDINE 5'-MONOPHOSPHATE (FDUMP) AGAINST MURINE LYMPHOMA L5178Y RESISTANT TO 5-FLUORO-2'-DEOXYURIDINE
- ANTITUMOR ACTIVITY OF QUINOCARMYCIN AGAINST CARCINOMA OF THE LUNG IN HUMAN TUMOR CLONOGENIC ASSAY
- COMPARATIVE STUDIES OF PULSE AND CONTINUOUS EXPOSURE IN HUMAN TUMOR CLONOGENIC ASSAY
- THE USE OF HUMAN TUMOR CLONOGENIC ASSAY IN PREDICTING COMBINATION EFFECT OF CISPLATIN PLUS VINDESINE IN CARCINOMA OF THE LUNG
- IN VITRO CHEMOSENSITIVITY PATTERNS OF CARCINOMA OF THE LUNG IN HUMAN TUMOR CLONOGENIC ASSAY